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Background and aims: To assess whether monosodium glutamate (MSG) intake is 
associated with sleep disordered breathing (SDB).   
Methods: Data from 1227 Chinese who participated in the Jiangsu Nutrition Study 
(JIN) were analyzed. All the participants were examined at two time points (2002  5 
baseline and 2007 follow-up). MSG intake was quantitatively assessed in 2002 and a 
sleep questionnaire was used to assess snoring, and to construct a SDB probability score 
in 2007. We define those within the fifth quintile of the score (highest) as having a high 
probability of SDB.   
Results MSG intake was positively associated with snoring and high probability of  10 
SDB among participants with normal body weight but not overweight. Comparing 
extreme quartiles of MSG intake among people with BMI<23, the OR for snoring was 
2.02 (95% confidence interval (CI): 1.02, 4.00), and the OR for a high probability of 
SDB was 3.11 (95% CI: 1.10, 8.84).There was a joint effect between MSG and 
overweight in relation to SDB.   15 
Conclusion MSG intake may increase the risk of sleep disordered breathing among 









Sleep-disordered breathing (SDB) encompasses a range of breathing abnormalities that 
occur during sleep, including obstructive sleep apnoea (OSA), central sleep apnoea and 
periodic breathing [1]. Snoring which may occur independently of OSA is a common  5 
manifestation of this disorder and prevalent in the general population worldwide [2, 3]. 
SDB is related to an increased risk of a range of diseases, including hypertension [4], 
diabetes [1, 5], metabolic syndrome [6], cardiovascular disease [7] and stroke [2]. 
 
Obesity is the most important risk factor for SDB; other possible lifestyle factors  10 
relating to SDB are smoking and alcohol drinking [2, 8]. Men have a higher risk of SDB 
than premenopausal, but not postmenopausal women [2, 8], suggesting that estradiol 
may be protective.  
 
Monosodium glutamate (MSG) is a widely used flavour enhancer. In 1968, Kwok  15 
reported a possible link between MSG and “Chinese restaurant” syndrome including 
symptoms of numbness, weakness, and heart palpitations [9]. Since then, a range of 
studies have claimed an association between MSG and health outcomes, including 
asthma, diabetes, obesity, and allergic rhinitis [10-12]. Glutamate is an excitatory 
neurotransmitter that is intimately involved with sleep-wake states [13], and has been  20 
shown to activate a number of brain areas [14], for example the insular cortex, anterior 
cingulate gyrus, and amygdala [15] which play a crucial role in the central regulation of 
the autonomic nervous system. The insular cortex in particular is associated with the 
regulation of breathing during sleep [15].  The objective of this study was to assess the 
association of MSG intake with SDB based on a large population-based study in China,  25 





MATERIALS AND METHODS 
 
Subjects 
The JIN cohort study of persons aged 20 years or older and the methods of sampling  5 
have been described previously [16]. In 2002, 2849 adults aged 20 and above living in 
two cities and six rural areas took part in a Chinese National Nutrition and Health 
Survey. In 2002, information relating to food intake and sleep duration was obtained by 
questionnaire [17, 18]. In 2007, an attempt to re-contact all original participants was 
made. Some had either moved to other cities for temporary work or moved to other  10 
streets within the urban area. Therefore, of the original 2849 participants, 1682 were 
identified for follow-up. Overall, 1492 (52.3% of the original cohort) participated in the 
follow-up interview, and of these190 participants refused clinical evaluation, thus 
height and weight measurements were obtained from 1282 (45.0%). In addition 210 
participants completed the interview at home but missed the measurement in the clinic.  15 
For the analysis we excluded those participants who had extreme values of weight 
change (i.e. > 20 kg, n=11), and those who had known diabetes, stroke, or cancer at 
baseline (n=40). Four participants also had missing values for MSG intake at baseline. 
The final sample size examined for weight change consisted of 509 men and 718 
women (total n=1227). Compared with the retained participants, those lost to follow-up,  20 
were generally younger (45.5 vs 49.3 years) but there were no differences in the mean 
BMI or energy intake. The study was conducted according to the guidelines laid down 
in the Declaration of Helsinki and all procedures involving human subjects/patients 
were approved by Jiangsu Provincial Centre for Disease Control and Prevention. 
Informed consent was obtained from each participant.  25 




Participants were interviewed at their homes by health workers using a standard 
questionnaire in 2002 and 2007
 [16]. The health workers were intensively trained in all 
aspects of data collection. 
 
Outcome variables-Sleep Questionnaire at follow-up  5 
In 2007, each participant was asked for information regarding their sleep. The sleep 
questionnaire was adopted from a Finnish questionnaire that has been used to screen for 
sleep disturbances and sleep apnoea [19]. The questionnaire was validated in Europe but 
not in China. The respondents were asked if their bedfellows had noticed breathing 
pauses during their sleep and subsequently these were classified as ‘witnessed apnoeas’.  10 
Additionally, the following three questions were recorded in a five point scale (0 = 
‘never’, 1 = ‘seldom’, 2 = ‘sometimes’, 3=‘often’ and 4 = ‘very often’): (i) How often 
do you wake up during the night? (ii) Do you feel excessively sleepy during the 
daytime? (iii) Do you fall asleep involuntarily during the daytime? Snoring was assessed 
by question “Do you snore loudly? 1) no 2) yes 3) do not know”. A positive answer was  15 
defined as snoring and given a score of 2, while a negative answer was given a score of 
0. The answers to these questions demonstrated possible sleep disturbances among the 
study subjects. The sum of the four questions was calculated, in order to detect an SDB 
probability score (0-14 points). We define those within the fifth quintile of the score 
(highest) as high probability for SDB (SDB probability score ≥5). In our study  20 
population the SDB score was much lower than the Finnish population, thus we decided 
to use a lower cut-off than the one used by Tumilehto et al [19]. 
At both baseline and follow up, sleep duration was established by the question “how 




Dietary intake: In 2002, dietary intake patterns during the previous year were 
investigated by a series of detailed questions about the usual frequency and quantity of 
intake of 33 food groups and beverages. The food frequency questionnaire (FFQ) has 
been validated [20] and reported to be a useful method for the collection of individual 
food consumption information in face-to-face interviews, but not in self-administered  5 
surveys, due to the current educational level of the majority of the Chinese population.  
Exposure variable- Baseline MSG intake  
To determine the amount of MSG and other seasonings consumed by individuals, each 
household was specifically asked about their usual monthly consumption of these items. 
Individual consumption of MSG was calculated according to the total amount of MSG  10 
consumed in the household divided by the number of individuals per household and 
then adjusted for the proportion of the household energy intake energy consumed by 
each individual. Average total glutamate intake was also calculated by adding the 
glutamate concentrations of all foods/seasonings consumed by an individual per day. 
Nutrient (e.g. sodium, potassium, fibre) and vegetable oil intakes were assessed using a  15 
3-day weighed food diary which recorded all foods consumed by each individual, on 
three consecutive days; this was done to confirm the intakes reported from the FFQ 
data. We did not consider under- and over-report of energy intake to be an issue, 
because upon reviewing the food diaries with the subjects, the health workers would 
clarify any intake value for a particular food that fell below or above the usual value  20 
reportedly consumed by the population within the region. Not everyone was asked for 
dietary information at follow up (FFQ was only used among those 15 years and above) 
however the household MSG intake was determined, thus mean household MSG intake 




Composition Table. In the current analysis, energy and nutrient intake was calculated 
using a 3-day weighted food diary. 
Dietary patterns: Dietary patterns were identified by factor analysis based on food 
intake measured by the food frequency questionnaire (FFQ), using standard principal 
component analysis as described elsewhere. [17] In short, four food patterns were  5 
obtained - Factor 1 (‘macho’) was characterized by various kinds of animal foods and 
alcohol, i.e. foods commonly consumed by men; Factor 2 (the ‘traditional’ pattern) 
loaded heavily on rice, fresh vegetables and inversely on wheat flour; Factor 3 (‘sweet 
tooth’) contained cake, milk, yoghurt and drinks; and Factor 4 (‘vegetable rich’ pattern) 
included whole grains, fruits, root vegetables, fresh and pickled vegetables, milk, eggs  10 
and fish. The four factors explained 28.5% of the variance in intake.  
 
Other lifestyle factors: Cigarette smoking was assessed by asking the frequency of daily 
cigarette smoking. Information on passive smoking was asked. Eating out was assessed 
by asking whether individuals ate out on a frequent basis and was coded as yes or no.  15 
Alcohol consumption was assessed by asking the frequency and amount of alcohol 
consumed. Questions on daily commuting were grouped into three categories - (1) using 
motorized transportation, or no work (0 minute of walking or cycling), (2) walking or 
bicycling 1-29 minutes, and (3) walking or bicycling for  30 minutes. Daily leisure 
time physical activity was grouped into three categories: 0, 1-29, and ≥ 30 minutes.  20 
Time spent on sedentary activities each day (viewing television, operating computer, 
playing video games and reading during leisure time) was classified into four 
categories: <1, 1-1.9, 2-2.9, and ≥3 hours. Education was recoded into either ‘Low’ 
(illiteracy, primary school); ‘Medium’ (junior middle school); or, ‘High’ (high middle 




Occupation was recoded into ‘Manual’ or ‘Non-manual’ based on a question with 12 
occupational categories. Antihypertensive medication use (yes/no) was asked at 
baseline and follow-up. 
 
Anthropometric measurements: In both 2002 and 2007, anthropometric measurements  5 
were obtained using standard protocols and techniques. Body weight was measured in 
light indoor clothing without shoes to the nearest 100 grams. Height was measured 
without shoes to the nearest mm using a stadiometer. Overweight was defined as BMI 
≥23 Kg/m
2 .Waist circumference was measured to the nearest mm midway between the 
inferior margin of the last rib and the crest of the ilium, in the mid-axillary line in a  10 
horizontal plane. Blood pressure was measured twice by mercury sphygmomanometer 
on the right upper arm of the subject, who was seated for 5 min before the 
measurement. The mean of these two measurements was used in the analyses. 
Hypertension was defined as systolic blood pressure above 140 mmHg and/or diastolic 
blood pressure above 90 mmHg, or using antihypertensive drugs.  15 
 
Statistics 
MSG intake was recoded into quartiles. Chi square tests were used to compare the 
difference between categorical variables, and ANOVA was used to compare differences 
in continuous variables between groups. Multilevel logistic regression was used to  20 
determine the association between MSG intake (quartiles) and snoring and high 
probability for SDB adjusted for age, education, occupation, active commuting, leisure 
time physical activity, smoking, passive smoking, alcohol drinking, eating out, 
overweight, and energy intake. These multivariate models were adjusted for household 




MSG intake by assigning each participant the median value for the category and 
modelling this value as a continuous variable. Food patterns were also put into the 
multivariate models to control for the residual confounding. Hypertension was not 
adjusted in the multivariate analysis because of its collinearity with overweight. All the 
analyses were performed using STATA 11 (Stata Corporation, College Station).  5 
Multiplicative interaction between MSG intake and sex/hypertension was tested using 
the likelihood ratio test by adding the product of MSG intake and sex/hypertension in 
the multivariate model. Statistical significance was considered to be when p < 0.05 (two 
sided).  





The mean intake of MSG for the entire population was 3.8 g/day (SD, 4.3). Of the 1227 
participants, 72 reported no use of MSG and the median intakes across the quartiles 
were 0.8, 2.0, 3.7 and 6.9 g/d, respectively. Table 1 shows the cross-sectional 
associations between MSG intake, nutrients and specific food items or food groups.  5 
MSG intake was positively associated with fat intake (P < 0.001) but inversely 
associated with carbohydrate intake (P < 0.001). No significant difference in energy and 
protein intake was found across MSG intake quartiles. Total glutamate was the same in 
quartiles one to three but was on average 37% greater in quartile four (P < 0.001). At 
baseline, the overall prevalence of overweight/obesity (BMI ≥ 23 kg/m2) was 51.3%.  10 
MSG intake was inversely related to BMI and central obesity at baseline. 
 
Of the sample, 36% reported snoring (52.4% in men, 25.7% in women), and 3.6% had 
witnessed apnoea (5.5% in men, 2.3% in women). Across the quartiles of MSG intake, 
the prevalence of snoring increased from 46.5% to 54.0% in men (p=0.110), 18.1% to  15 
28.2% in women (p=0.024), 27.5% to 42.0% in gender combined (p<0.001).  Both the 
mean SDB probability score and the percentage of high SDB probability score 
increased with increased MSG intake. No association between MSG intake and 
witnessed apnoea was found. At baseline, high MSG intake was associated with short 
sleep duration (Table 2).   20 
 
In multivariate analyses adjusting for age, gender, overweight/obesity, lifestyle factors 
as well as dietary factors including dietary patterns (Table 3), baseline MSG intake was 
positively associated with snoring at follow up.  Comparing the extreme quartiles of 




probability of SDB was 2.40(1.22, 4.58). A positive association between total glutamate 
intake and snoring and a high probability of SDB was found (data not shown).  
Overweight/obesity was positively associated with both snoring and SDB in 
multivariate analysis (data not shown). Stratified analyses showed a significant positive 
association between MSG intake and snoring and high probability of SDB among  5 
participants with normal BMI. Across the quartiles of MSG intake, among participants 
with normal BMI, the OR’s were 1, 1.10 (0.56, 2.20), 2.19(1.10, 4.36) and 2.02(1.02, 
4.00) for snoring; 1, 1.31(0.49, 3.52), 1.65(0.58, 4.63), and 3.11(1.10, 8.84) for a high 
probability of SDB.   These associations were not statistically significant among 
participants with BMI≥23.  10 
A joint effect between MSG intake and overweight in relation to snoring and a high 
probability of SDB was also found (Figure 1). In this case, overweight was positively 
associated with snoring and a high probability of SDB. 
No significant interaction between MSG intake and sex or hypertension was found (data 
not shown). Among those who reported taking hypertensive medication (n=215), there  15 






In this study, we found a positive association between the intake of MSG at baseline 
and snoring and SDB at follow up among Chinese adults with normal body weight. 
There was a significant additive interaction between overweight and MSG intake in 
relation to snoring and SDB. There was a similar association between total glutamate  5 
intake and snoring and SDB. To our knowledge, this is the first population study to 
report an association between MSG intake and SDB.  
 
The prevalence of snoring (36%) in our sample is consistent with that of other studies in 
China, although  because of age related differences in the cohorts studied, and the  10 
increase in snoring with increasing age, direct comparison is not possible. In the 
Guangzhou Biobank Cohort Study, 80.0% of the Chinese participants aged 50-85 years 
reported snoring [7], while the prevalence of snoring was 23% among men living in 
Hong Kong with a mean age of 41 years [3].  The prevalence of OSA in the Chinese 
population is lower than Western populations [3]. In our study, the proportion of  15 
‘witnessed apnoea’ is much lower than in Finland [19].  
 
Apart from anatomical abnormalities of the upper airway, and severe obesity, there are 
other factors that may also play a role in the genesis of SDB including upper airway 
dilator muscle dysfunction, lung capacity and instability in breathing control [21]. MSG  20 
has been shown to induce activation of vagal pathways via glutamate receptors in the 
proximal gastrointestinal tract, and to modify gut motility [22]. Gastroesophageal reflux 
disease (GERD) has been found to be associated with OSA [23] A study in Shanghai 
showed that the prevalence of GERD in adults, defined as heartburn and/or 




population studies in China found an association between GERD and sleep disorders 
[25]. Heartburn is a common complaint in relation to the “Chinese Restaurant 
Syndrome” [26] and given the effects of MSG on gastro-intestinal motility it possible 
that increased reflux is a mediating factor. Interestingly ADX10059, a metabotropic 
glutamate receptor-5 negative allosteric modulator, has been found to be effective in the  5 
treatment of GERD [27].  
 
An association between MSG intake and chronic rhinitis has been described in a single 
case report [28]. We do not have information on rhinitis in this study, but the prevalence 
of allergic rhinitis in the study area is about 10% [29]. Whether rhinitis mediates the  10 
effect of MSG on SDB remains to be determined.  
 
The relationship between body weight, MSG and SDB is complex. Consistent with 
current knowledge, overweight/obesity was positively associated with SDB in our 
sample. We found a strong positive association between MSG and SDB in lean  15 
individuals. Using the group with normal weight and low MSG intake as reference, 
those who were overweight and had high intake of MSG had in general a higher risk of 
SDB. However, in stratified analysis, using overweight and low MSG intake as 
reference, the association between MSG intake and SDB among overweight group 
became marginally significant (p for trend=0.141). This discrepancy may suggest that  20 
unmeasured confounding factors exist. An inverse association between MSG intake and 
BMI/central obesity at baseline was also noted and this suggests the relationship 
between MSG and SDB may occur through other mechanisms and not be dependent on 
the presence (or absence) of obesity. Despite the difference in reported prevalence of 





The main limitation of this study is the use of self-reported sleep data instead of the 
more valid polysomnographic method to confirm the diagnosis of SDB. However, 
questionnaires have previously been found to be useful and are widely accepted in 
detecting and screening for SDB in large epidemiological studies [19]. Although the  5 
measurement of sleep data was only done in the follow up and a causal relationship 
cannot be established, a high proportion of those with snoring or SDB could be 
expected to be new cases as the development of snoring and SDB is higher before the 
age 65 years. Another limitation is the measurement of MSG consumption was 
determined by the total amount of MSG consumed in the household divided by the  10 
number of individuals per household and then adjusted for the proportion of the 
household energy intake energy. This method may under or overestimate MSG intake, 
although in a large epidemiological study, this would be the most practical way of 
measuring MSG consumption.  Other limitations include the inability to account for a 
change in MSG consumption during the 5 year follow-up period. Data from the China  15 
Health and Nutrition Survey (CHNS) showed that since 2000 the MSG intake in China 
has decreased: the median intake of MSG was 5.4, 5.9, 4.7, 4.7 g in 1997, 2000, 2004, 
and 2006 respectively among those high MSG consumers (fifth quintile of MSG intake) 
[30]. This trend could be due to the public awareness of the effects of MSG intake on 
health outcomes. The association between MSG intake and SDB in our study will be  20 
underestimated if those with high intake of MSG decreased their intake during the 
follow up. The high rate of lost to follow up may introduce bias and limit the power to 





Nevertheless, the strength of the observation that a high MSG intake is positively 
associated with SDB in a large population study in Chinese adults with normal body 
weight, and the joint effect of MSG intake and overweight in relation to snoring and 
high probability for SDB is of potential public health importance and warrants further 
examination.  5 
 
Authorship 
ZS had full access to all data in the study and takes responsibility for the integrity of the 
data and the accuracy of the data analysis. ZS devised the study concept; ZS, BY, YD, 
and HZ acquired the data; ZS conducted the statistical analysis and drafted the  10 
manuscript; GAW, BY, YD, TKG, GH, RA, HZ, and AWT critically revised the 
manuscript for important intellectual content. 
Guarantor: Shi Z 
Acknowledgements 
The authors thank the participating Regional Centers for Disease Control and  15 
Prevention in Jiangsu Province, including the Nanjing, Xuzhou, Jiangyin, Taicang, 
Suining, Jurong, Sihong and Haimen Centers, for their support in the data collection. 
The study is supported by Jiangsu Provincial Natural Science Foundation (BK2008464) 
and the Jiangsu Provincial Health Bureau, China. 
DISCLOSURE STATEMENT   20 
Shi Z, Wittert G, Yuan B, Dai Y, and Taylor A received research grant from 
International Glutamate Technical Committee, but not related to the current study. All 







[1]  Shaw JE, Punjabi NM, Wilding JP, Alberti K, Zimmet PZ. Sleep-disordered 
breathing and type 2 diabetes - A report from the International Diabetes Federation 
Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract. 2008;81:2-12. 
[2]  Punjabi NM. The Epidemiology of Adult Obstructive Sleep Apnea. Proc Am  5 
Thorac Soc. 2008;5:136-43. 
[3]  Ip MSM, Lam B, Lauder IJ, Tsang KWT, Chung KF, Mok YW, et al. A 
community study of sleep-disordered breathing in middle-aged Chinese men in Hong 
Kong. Chest. 2001;119:62-9. 
[4]  Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association  10 
between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-
84. 
[5]  Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB. Snoring as a 
risk factor for type II diabetes mellitus: A prospective study. Am J Epidemiol. 
2002;155:387-93.  15 
[6]  Angelico F, del Ben M, Augelletti T, de Vita R, Roma R, Violi F, et al. 
Obstructive sleep apnoea syndrome and the metabolic syndrome in an internal medicine 
setting. Eur J Intern Med. 2010;21:191-5. 
[7]  Thomas GN, Jiang CQ, Lao XQ, McGhee SM, Zhang WS, Schooling CM, et al. 
Snoring and vascular risk factors and disease in a low-risk Chinese population: The  20 
Guangzhou Biobank Cohort Study. Sleep. 2006;29:896-900. 
[8]  Young T, Peppard PE, Gottlieb DJ. Epidemiology of Obstructive Sleep Apnea: 
A Population Health Perspective. Am J Respir Crit Care Med. 2002;165:1217-39. 
[9]  Kwok RHM. Chinese-restaurant syndrome. N Engl J Med. 1968;278:796. 
[10]  Beyreuther K, Biesalski HK, Fernstrom JD, Grimm P, Hammes WP, Heinemann  25 
U, et al. Consensus meeting: monosodium glutamate - an update. Eur J Clin Nutr. 
2007;61:304-13. 
[11]  Williams AN, Woessner KM. Monosodium glutamate 'allergy': menace or 
myth? Clin Exp Allergy. 2009;39:640-6. 
[12]  He K, Zhao L, Daviglus ML, Dyer AR, Van Horn L, Garside D, et al.  30 
Association of Monosodium Glutamate Intake With Overweight in Chinese Adults: The 




[13]  Burgess C, Lai D, Siegel J, Peever J. An endogenous glutamatergic drive onto 
somatic motoneurons contributes to the stereotypical pattern of muscle tone across the 
sleep-wake cycle. J Neurosci. 2008;28:4649-60. 
[14]  Kitamura A, Sato W, Uneyama H, Torii K, Niijima A. Effects of intragastric 
infusion of inosine monophosphate and L: -glutamate on vagal gastric afferent activity  5 
and subsequent autonomic reflexes. J Physiol Sci. 2011;61:65-71. 
[15]  Nagai M, Hoshide S, Kario K. The insular cortex and cardiovascular system: a 
new insight into the brain-heart axis. J Am Soc Hypertens. 2010;4:174-82. 
[16]  Shi Z, Luscombe-Marsh ND, Wittert GA, Yuan B, Dai Y, Pan X, et al. 
Monosodium glutamate is not associated with obesity or a greater prevalence of weight  10 
gain over 5 years: findings from the Jiangsu Nutrition Study of Chinese adults. Br J 
Nutr. 2010;104:457-63. 
[17]  Shi Z, Hu X, Yuan B, Hu G, Pan X, Dai Y, et al. Vegetable rich food pattern is 
related to obesity in China. Int J Obes (Lond). 2008 32:975-84. 
[18]  Shi Z, McEvoy M, Luu J, Attia J. Dietary fat and sleep duration in Chinese men  15 
and women. Int J Obes. 2008;32:1835-40. 
[19]  Tuomilehto H, Peltonen M, Partinen M, Seppä J, Saaristo T, Korpi-Hyövälti E, 
et al. Sleep-disordered breathing is related to an increased risk for type 2 diabetes in 
middle-aged men, but not in women- the FIN-D2D survey. Diabetes Obes Metab. 
2008;10:468-75.  20 
[20]  Zhao W, Hasegawa K, Chen J. The use of food-frequency questionnaires for 
various purposes in China. Public Health Nutr. 2002;5:829-33. 
[21]  Owens RL, Eckert DJ, Yeh SY, Malhotra A. Upper airway function in the 
pathogenesis of obstructive sleep apnea: a review of the current literature. Curr Opin 
Pulm Med. 2008;14:519-24.  25 
[22]  Toyomasu Y, Mochiki E, Yanai M, Ogata K, Tabe Y, Ando H, et al. Intragastric 
monosodium L-glutamate stimulates motility of upper gut via vagus nerve in conscious 
dogs. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1125-35. 
[23]  Jung HK, Choung RS, Talley NJ. Gastroesophageal reflux disease and sleep 
disorders: evidence for a causal link and therapeutic implications. J Neurogastroenterol  30 
Motil. 2010;16:22-9. 
[24]  Ma XQ, Cao Y, Wang R, Yan X, Zhao Y, Zou D, et al. Prevalence of, and 
factors associated with, gastroesophageal reflux disease: a population-based study in 




[25]  Chen MJ, Wu MS, Lin JT, Chang KY, Chiu HM, Liao WC, et al. 
Gastroesophageal reflux disease and sleep quality in a Chinese population. J Formos 
Med Assoc. 2009;108:53-60. 
[26]  Lacy BE, Weiser K, Chertoff J, Fass R, Pandolfino JE, Richter JE, et al. The 
Diagnosis of Gastroesophageal Reflux Disease. Am J Med. 2010;123:583-92.  5 
[27]  Keywood C, Wakefield M, Tack J. A proof-of-concept study evaluating the 
effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric 
modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease. Gut. 
2009;58:1192-9. 
[28]  Asero R, Bottazzi G. Chronic rhinitis with nasal polyposis associated with  10 
sodium glutamate intolerance. Int Arch Allergy Immunol. 2007;144:159-61. 
[29]  Han DM, Zhang L, Huang D, Wu YF, Dong Z, Xu G, et al. Self-reported 
prevalence of allergic rhinitis in eleven cities in China. Zhonghua Er Bi Yan Hou Tou 
Jing Wai Ke Za Zhi. 2007;42:378-84. 
[30]  He K, Du S, Xun P, Sharma S, Wang H, Zhai F, et al. Consumption of  15 
monosodium glutamate in relation to incidence of overweight in Chinese adults: China 









Figure 1: Joint effects of MSG intake and overweight in relation to a) snoring b) high 
probability for SDB. OR adjusted for variables in model 2 of Table 3. * p<0.05, ** 
p<0.01. 5  
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Table 1 Baseline Sample Characteristics According to MSG Intake Quartiles among Chinese Adults 
a 
 
Q1 (low), 0.8 
g/day (median) 
N = 307 
Q2, 2.0 g/day 
N =307  
Q3, 3.7 g/day 
N =307 
Q4 (high), 6.9 
g/day 
N =306  P
 b  
Energy (kJ/day) 
c  9706(142)  9898(142)  9643(142)  9765(146)  0.638 
Fat (g/day) 
d  73.9(1.4)  81.3(1.4)  84.5(1.4)  86.7(1.4)  <0.001 
Protein (g/day) 
d  72.1(0.8)  72.2(0.8)  72.6(0.8)  72.4(0.8)  0.974 
Carbohydrate (g/day) 
d   336.5(3.4)  321.0(3.4)  310.4(3.4)  300.6(3.4)  <0.001 
Fiber (g/day) 
d  16.0(0.5)  11.8(0.5)  9.0(0.5)  9.5(0.5)  <0.001 
Glutamate (g/day) 
d  14.2(0.3)  14.0(0.3)  13.9(0.3)  19.2(0.3)  <0.001 
Vegetables (g/day) 
c  259(9)  256(9)  259(9)  264(9)  0.946 
Fruits (g/day) 
c  57(5)  57(5)  54(5)  59(5)  0.914 
Alcohol intake (g/day)  1.8(0.3)  1.7(0.3)  1.7(0.3)  1.9(0.3)  0.954 
Men (%)  33.2  35.2  44.0  53.6  <0.001 
Age (years)  48.2(0.8)  50.0(0.7)  49.6(0.8)  48.2(0.7)  0.200 
Urban (%)  24.8  16.9  4.2  6.5  <0.001 
Weight (kg) 
 c  60.3(0.5)  60.4(0.5)  59.5(0.5)  58.5(0.5)  0.045 
Waist circumference (cm) 
c  79.8(0.5)  79.3(0.5)  78.4(0.5)  76.9(0.5)  0.001 
Central obesity (%) 
e  36.6  32.9  27.8  21.2  <0.001  
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Obesity (%) (BMI≥28 kg/m
2)  12.4  10.1  8.1  5.2  0.016 
Overweight/obesity (%)(BMI≥23 kg/m
2)  53.4  53.8  55.1  43.1  0.011 
BMI (kg/m
2) 
c  23.6(0.2)  23.6(0.2)  23.4(0.2)  22.9(0.2)  0.016 
Hypertension (%)  30.9  32.3  31.6  26.1  0.339 
Low Education (%)    58.0  55.1  53.4  46.1  0.005 
Manual job (%)  56.4  53.1  50.8  47.4  0.154 
Active commuting (%)           
  None  37.1  39.4  39.1  46.4   
  1-29 minutes/day  46.3  48.2  51.5  48.7  <0.001 
  ≥30 minutes/day  16.6  12.4  9.5  4.9   
No leisure time physical activity  89.9  90.2  92.2  94.4  0.130 
Sedentary activity ≥3 hr/day (%)  9.1  11.7  9.5  17.0  <0.001 
Smoker (%)  23.1  21.2  28.7  36.0  <0.001 
Alcohol drinker (%)  19.2  19.9  26.1  34.0  <0.001 
Abbreviations: BMI, body mass index; MSG, Monosodium Glutamate. Q1-4, quartiles 1-4. 
a  values are mean (SE), or percentage (%). 
b p values were generated by chi-squared test for categorical variables and ANOVA test for continuous exposures. 
c Adjusted for age and sex. 
d Adjusted for age and sex and energy intake. 
e Defined as waist circumference: men ≥90 cm, women ≥80 cm.  
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Table 2 Association between Baseline MSG Intake (Quartiles) and Sleep Related 
Measurements among Chinese Adults in Jiangsu Nutrition Study (n=1227) 
  MSG intake quartiles in 2002   











Sleep categories (baseline) (h/d) 
(%) 
         
  7-8  68.8  63.2  70.7  71.2   
  <7  9.2  13.2  12.5  17.1  0.001 
  ≥9  22.0  23.7  16.8  11.8   
Sleep categories at follow up (h/d) 
(%) 
         
  7-8  71.7  62.4  65.9  72.2   
  <7  16.6  20.9  20.7  16.3  0.123 
 ≥9  11.7  16.7  13.4  11.4   
Snoring (%)           
   Men   46.5  46.3  59.7  54.0  0.110 
   Women   18.1  27.4  30.8  28.2  0.024 
   Both genders  27.5  34.1  43.5  42.0  <0.001 
Witnessed apnoea (%)  2.3  4.6  3.6  3.9  0.488 
High probability for SDB (%)  15.1  19.1  20.7  25.9  0.010 
Mean probability for SDB score           
  mean  2.2  2.4  2.7  3.1  <0.001 
  SD  2.3  2.4  2.1  2.2   
 
Abbreviations: MSG, Monosodium Glutamate; SDB, sleep disordered breathing; SD, 
standard deviation. Q1-4, quartiles 1-4. 
a Median MSG intake with quartile. 
b P values were generated by chi-squared test for categorical variables and ANOVA 
test for continuous exposures.  
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Table 3 Odds ratio (95%CI) for Snoring and SDB According to Monosodium Glutamate Intake Quartiles Among Chinese Adults in Jiangsu 
Nutrition Study (n=1227) 
   MSG intake quartiles in 2002 
  
  
   Q1 (0.8 g/day)
a  Q2(2.0 g/day)  Q3 (3.7 g/day)  Q4 (6.9 g/day)  P 
b 
  OR  OR  95%CI  OR  95%CI  OR  95%CI   
Snoring in 2007                 
 BMI<23                 
    Model 1 
c  1.00  1.16   0.60, 2.23   2.48   1.31, 4.69   2.28   1.22, 4.25   0.005 
    Model 2
 d  1.00  1.10   0.56, 2.20   2.19   1.10, 4.36   2.02   1.02, 4.00   0.030 
 BMI≥23                 
    Model 1 
c  1.00  1.63   0.92, 2.89   1.76   0.99, 3.11   1.56   0.84, 2.91   0.251 
    Model 2
 d  1.00  1.82   1.00, 3.32   1.81   0.97, 3.38   1.53   0.77, 3.03   0.434 
All sample                 
    Model 1 
c  1.00  1.45   0.93, 2.25   2.06   1.33, 3.20   1.77   1.13, 2.76   0.019 
    Model 2
 d  1.00  1.64   1.02, 2.62   2.16   1.32, 3.52   1.91   1.16, 3.17   0.036 
High probability for SDB in 2007                 
BMI<23                 
    Model 1 
c  1.00  1.37   0.53, 3.51   1.83   0.72, 4.66   3.17   1.24, 8.07   0.010 
    Model 2
 d  1.00  1.31   0.49, 3.52   1.65   0.58, 4.63   3.11   1.10, 8.84   0.020 
BMI≥23                 
    Model 1 
c  1.00  1.36   0.64, 2.90   1.24   0.57, 2.66   2.00   0.88, 4.53   0.121 
    Model 2
 d  1.00  1.16   0.53, 2.55   1.06   0.46, 2.43   1.92   0.79, 4.66   0.141 
All sample                 
    Model 1 
c  1  1.40   0.81, 2.43   1.61   0.92, 2.81   2.54   1.44, 4.49   0.005  
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    Model 2
 d  1  1.22   0.66, 2.26   1.26   0.66, 2.42   2.4   1.22, 4.68   0.007 
Abbreviations: BMI, body mass index; CI, confidence interval; MSG, Monosodium Glutamate; OR, odds ratio; SDB, sleep disordered breathing; 
Q1-4, quartiles 1-4. 
a Median MSG intake with quartile. 
b P value from a linear trend test. 
c Model 1 adjusted for age and sex 
d Model 2 adjusted for age, sex, smoking (yes/no), alcohol drinking (yes/no), passive smoking (yes/no) , active commuting (no, 1-29 
minutes/day, ≥30 minutes/day), leisure time physical activity (no, 1-29 minutes/day, >30 minutes/day), sedentary activity(<1 hrs/day, 1-1.9 
hrs/day, 2-2.9 hrs/day,≥3 hrs/day), education (low, medium, high), and occupation (manual/non-manual), central obesity (defined as waist 
circumference: men ≥90 cm, women ≥80 cm), eating out, total energy intake, and dietary patterns (see ref 17). For the analyses in all sample, 
model 2 also adjusted for overweight (BMI≥23, yes/no). 
 